NASDAQ:AWH
Aspira Women's Health Inc. Stock News
$2.66
+0.0200 (+0.758%)
At Close: May 17, 2024
Aspira Women's Health, Inc. (AWH) CEO Valerie Palmieri on Q2 2020 Results - Earnings Call Transcript
10:58pm, Thursday, 13'th Aug 2020
Aspira Women's Health, Inc. (NASDAQ:AWH) Q2 2020 Earnings Conference Call August 13, 2020, 16:30 ET Company Participants Valerie Palmieri - CEO, President & Director Lesley Northrop - Global Medic
Aspira Women’s Health Reports Second Quarter 2020 Financial Results
08:01pm, Thursday, 13'th Aug 2020
Conference Call scheduled for today, August 13th at 4:30 p.m. ETAUSTIN, Texas, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based wome
Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th
01:23pm, Friday, 31'st Jul 2020
AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the s
Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares
10:30am, Wednesday, 08'th Jul 2020
Those following along with Aspira Women's Health Inc. (NASDAQ:AWH) will no doubt be intrigued by the recent purchase...
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million
03:23pm, Wednesday, 01'st Jul 2020
The closing of the private placement is expected to occur on July 6, 2020, subject to customary closing conditions. At the closing, ASPIRA will receive approximately $11 million in gross proceeds, be
Aspira Women’s Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring
12:00pm, Monday, 29'th Jun 2020
Aspira Women’s Health, Inc. (AWH), a bioanalytical-based women’s health company, today announced the first patient enrolled in a national clinical study of benign pelvic mass management. The stud
